Table of contents

August 2007 Volume 4 No 8

Top

Editorial

Cardiac cell therapy: bench or bedside?

On behalf of the Steering Committee of the National Heart, Lung, and Blood Institute Cardiovascular Cell Therapy Research Network

403

doi:10.1038/ncpcardio0927 | Full Text | PDF (96K)

Top

Viewpoint

Familial hypercholesterolemia: a missed opportunity in preventive medicine

Gerald F Watts, Barry Lewis and David R Sullivan

404

Although familial hypercholesterolemia is eminently treatable, the majority of cases go undetected, and this disorder remains a major challenge for preventive medicine. In this timely Viewpoint, Gerald Watts, Barry Lewis, and David Sullivan discuss how new genetic screening initiatives, together with a co-operative approach to treatment, could result in a quantum leap for coronary disease prevention.

doi:10.1038/ncpcardio0941 | Full Text | PDF (134K)

Top

Research Highlights

Intervention increases adherence to guidelines for coronary heart disease prevention

406

doi:10.1038/ncpcardio0916 | Full Text | PDF (88K)

Short-term benefits of tolvaptan in hospital treatment of heart failure

406

doi:10.1038/ncpcardio0917 | Full Text | PDF (88K)

Prosthetic valve endocarditis: current perspectives

406

doi:10.1038/ncpcardio0918 | Full Text | PDF (97K)

Risk of renal complications in PCI reduced by prophylactic intravenous hydration

407

doi:10.1038/ncpcardio0919 | Full Text | PDF (86K)

The BARI trial—PTCA and CABG surgery produce equivalent long-term results in CAD

407

doi:10.1038/ncpcardio0920 | Full Text | PDF (98K)

Biomarker study validates link between trans fat consumption and coronary heart disease risk

408

doi:10.1038/ncpcardio0921 | Full Text | PDF (88K)

Rosuvastatin slows intima–media thickening in individuals with subclinical atherosclerosis

408

doi:10.1038/ncpendmet0525 | Full Text | PDF (99K)

Effects of reconstituted HDL cholesterol infusions on measurements of atherosclerosis

409

doi:10.1038/ncpendmet0544 | Full Text | PDF (88K)

Lowering salt intake reduces cardiovascular risk, as well as decreasing blood pressure

409

doi:10.1038/ncpendmet0549 | Full Text | PDF (88K)

Top

Practice Points

The COURAGE trial: is there still a role for PCI in stable coronary artery disease?

Spencer B King III

410

doi:10.1038/ncpcardio0939 | Full Text | PDF (136K)

Is weekend hospital admission associated with increased mortality in patients with acute myocardial infarction?

Gary E Rosenthal and Peter Cram

412

doi:10.1038/ncpcardio0931 | Full Text | PDF (136K)

Can a new algorithm improve diagnostic accuracy in wide QRS complex tachycardia?

Melvin M Scheinman

414

doi:10.1038/ncpcardio0936 | Full Text | PDF (133K)

Does aprotinin increase the long-term risk of mortality in patients undergoing CABG surgery?

Ken Taylor

416

doi:10.1038/ncpcardio0934 | Full Text | PDF (137K)

Top

Reviews

Etiology, pathogenesis and management of thoracic aortic aneurysm

Hüseyin Ince and Christoph A Nienaber

418

Diagnosis and medical care of most aortic pathologies is frequently the responsibility of cardiologists. With the emergence of endovascular interventions, it is, therefore, increasingly important for cardiologists to gain confidence in managing at least the most-frequent presentations of aortic disease. Here, Hüseyin Ince and Christoph Nienaber review the etiology, pathophysiology and clinical management of patients with thoracic aortic aneurysm, in the context of the most recent literature.

doi:10.1038/ncpcardio0937 | Full Text | PDF (549K)

Left atrial appendage closure for stroke prevention in atrial fibrillation: state of the art and current challenges

Tariqshah M Syed and Jonathan L Halperin

428

The majority of strokes in patients with atrial fibrillation (AF) are caused by formation of thrombi in the left atrial appendage (LAA). Surgical closure the LAA orifice has emerged as a promising therapy for patients with AF at high risk of stroke, particularly those who are unable to tolerate oral anticoagulants. Here Tariqshah Syed and Jonathan Halperin discuss minimally invasive approaches to LAA occlusion and the future of these procedures in stroke prevention.

doi:10.1038/ncpcardio0933 | Full Text | PDF (576K)

Obesity cardiomyopathy: pathogenesis and pathophysiology

Chiew Wong and Thomas H Marwick

436

Myocardial changes associated with the obese state are increasingly recognized and, notably, are independent of hypertension, obstructive sleep apnea and coronary artery disease. In the first part of this two-part Review, Chiew Wong and Thomas Marwick examine the range of evidence supporting the existence of cardiomyopathy of obesity, and discuss the possible mechanisms.

doi:10.1038/ncpcardio0943 | Full Text | PDF (290K)

Continuing Medical Education

Mechanisms of Disease: Toll-like receptors in cardiovascular disease

Stefan Frantz, Georg Ertl and Johann Bauersachs

444

Toll-like receptors are the primary innate immune receptors and could, therefore, be a key link between cardiovascular disease development and the immune system. Here, Stefan Frantz, Georg Ertl and Johann Bauersachs review this exciting field of research, and explore the evidence supporting a role for toll-like receptors in the pathophysiology of cardiovascular diseases.

doi:10.1038/ncpcardio0938 | Full Text | PDF (1,085K)

Top

Case Study

Continuing Medical Education

Percutaneous closure of a patent foramen ovale in left-sided carcinoid heart disease

Paru R Chaudhari, Jeffrey Abergel, Richard R Warner, Jerome Zacks, Barry A Love, Jonathan L Halperin and Eric Adler

455

doi:10.1038/ncpcardio0944 | Full Text | PDF (347K)

Extra navigation

.

ADVERTISEMENT